SCHEMBL3822734

SCHEMBL3822734

Cc1ccc(S(=O)(=O)ON(O)Cc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.55
CNR2 P34972 9/20 0.51
TAS2R14 Q9NYV8 1/20 0.51
POLB P06746 1/20 0.49
NR3C1 P04150 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
CNR1 P21554 1/20 0.47
ACHE P22303 2/20 0.46
BCHE P06276 1/20 0.46
CA12 O43570 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
ATM Q13315 1/20 0.46
CA9 Q16790 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.46
LIMK2 P53671 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11790689 0.85 MCHR1 (0.52) MCHR1CNR2TAS2R14POLBNR3C1
SCHEMBL28508064 0.83 MCHR1 (0.54) MCHR1CNR2TAS2R14POLBNR3C1
SCHEMBL11661989 0.76 CNR2 (0.56) MCHR1CNR2ALDH1A1ACHEBCHE
SCHEMBL6315850 0.75 CA12 (0.56) MCHR1CNR2NR3C1ALDH1A1LMNA
SCHEMBL6872283 0.75 MCHR1 (0.58) MCHR1CNR2TAS2R14POLBNR3C1
SCHEMBL10719271 0.74 MCHR1 (0.67) MCHR1CNR2TAS2R14POLBNR3C1
SCHEMBL2890 0.73 CA9 (0.53) MCHR1CNR2ALDH1A1LMNAACHE
SCHEMBL11785484 0.73 PPARG (0.43) TAS2R14POLBALDH1A1LMNACA12
SCHEMBL21835092 0.73 CNR2 (0.65) MCHR1CNR2TAS2R14NR3C1ALDH1A1
SCHEMBL5530229 0.73 MCHR1 (0.56) MCHR1CNR2TAS2R14POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097370-A2 COMPOUNDS AND METHODS FOR AMINO-ALKYLENEDIOL SYNTHESIS F. Hoffmann-Roche AG (CH) 2009-09-09 EP disclosed
WO-2008077799-A2 COMPOUNDS AND METHODS FOR AMINO-ALKYLENEDIOL SYNTHESIS F. HOFFMANN-LA ROCHE AG (CH) 2008-07-03 WO disclosed
US-20080154063-A1 Compounds and methods for amino-alkylenediol synthesis ROCHE PALO ALTO LLC 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154063-A1 Compounds and methods for amino-alkylenediol synthesis DAO, MSMO1, STS MCHR1 3040/4885CNR2 1723/4885TAS2R14 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.